SMAD2 and Barrett adenocarcinoma: In Barrett’s adenocarcinoma cells, Smad2/3 is phosphorylated in the presence of BMP7 and absence of TGF-β, but phosphorylation is inhibited with increasing concentrations of TGF-β (Rees et al., 2006).